April 10, 2017 Columns by admin Pick of the Week’s News: Progression, Antibiotics, Ocrevus, Stem Cells, B-Cells Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Canada, World’s Multiple Sclerosis Capital, Launches 3-Way Collaboration to Research MS Progression Why some people develop primary progressive MS and others have the relapsing type, and why a many relapsing patients develop secondary…
April 6, 2017 Columns by admin ‘Fabulous’ Ocrevus Lights the Way to a Brighter, Hopeful Future, MS Nurse Says Ocrevus is a “fabulous” drug that does wonders for those who respond to it. That’s the view of an MS nurse practitioner in Florida, with whom I spoke this week. Tricia Pagnotta works at the Multiple Sclerosis…
April 3, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Ocrevus and Its Approval, Reactions, Development, Dispensing, Other Countries Today, my Pick of the Week’s News is devoted to various news stories, all published by Multiple Sclerosis News Today, about FDA approval of Genentech’s Ocrevus as an MS treatment. FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms Last week’s approval of Ocrevus (ocrelizumab) by…
March 30, 2017 Columns by admin Dan Says Treasure Your Caregiving Hero Caregivers are in the spotlight during MS Awareness Month and, as it draws to a close, one man with multiple sclerosis is calling for everyone with the disease to recognize them. Dan Melfi, who lives in the…
March 27, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Clinical Trials, Rebif, Swallowing, Euthanasia, Patent Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. National MS Society-Sponsored Group Creates Tool Set to Measure Outcomes in MS Clinical Trials Speeding up clinical trials should have the knock-on effect of shortening the whole process of developing and approving new…
March 23, 2017 Columns by admin Benign MS: Is It Real or a Myth? What is benign MS? Does it even exist? Certainly it is not one of the types of the disease often listed as making up the multiple sclerosis family. It is a term that is surrounded by controversy,…
March 20, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Ocrevus, Myelin, Telemedicine, Gala and Axon Here is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Ocrevus and the hope of ‘ending MS forever’: Interview with MS Society’s Tim Coetzee Ocrevus possibly being one of the most significant advances in MS treatment, especially for people with PPMS, the…
March 16, 2017 Columns by admin After Long Wait, Zinbryta Gains Approval in Areas of the UK News that daclizumab, brand name Zinbryta, has been given the go-ahead to be available through the U.K.’s National Health Service (NHS) for treating relapsing MS, at least in part of the country, is good news. But why has the decision taken…
March 14, 2017 Columns by admin There’s Nothing Ordinary About New Novel Featuring Woman With MS Allison Wheeler is an unconventional heroine of a novel, but she found her way into my heart as I read A Million Ordinary Days by Judy Mollen Walters, a book being published today, March 14. Author Judy is also a BioNews Services columnist. She has Crohn’s disease and, writing…
March 13, 2017 by admin MS Patient’s Pick of the Week’s News: Useless Liberation Therapy, Immune System, After Obamacare, Aging with SPMS, IsolateMS Here is my Pick of the Week’s News, as published in Multiple Sclerosis News Today. ‘Liberation Therapy’ Is Useless, Costly, Potentially Dangerous, Study Finds At last, some positive research to debunk a supposed treatment that is not supported by any genuine repeatable research. To hear this ridiculous…
March 9, 2017 Columns by admin Let’s Compare MS Symptoms, and How We’re Handling Them We all know, because we have heard it so many times, that MS is not the same for everyone — that no two people have exactly the same combination of symptoms. That got me…
March 6, 2017 Columns by admin MS Patient’s Pick of the Week’s News: #MySupportHero, Awareness Video, Mind and Mobility, Seizures, Acthar Gel Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. MS Organizations Join #MySupportHero Initiative to Help Patients Salute Those Who Care Oh, I can see me fitting in well here. To see what I mean, just take a look at two previous…
March 2, 2017 Columns by admin Ocrevus: Counting Down to Expected FDA Approval There is now less than a month until the U.S. Food and Drug Administration (FDA) is expected to approve Ocrevus, generic name ocrelizumab, for use as a therapy for multiple sclerosis. Clinical trials have shown Genentech’s drug to be a promising therapy for relapsing MS and, significantly,…
February 27, 2017 Columns by admin #ACTRIMS2017 – MS Patient’s Pick of the Week’s News The ACTRIMS 2017 Forum is the source of my Pick of the Week’s News as published in Multiple Sclerosis News Today. There is Increased Evidence Linking Viruses to MS Risk This evidence goes some way toward justifying my view, previously published, about connections between viruses and MS. In particular,…
February 23, 2017 Columns by admin MS is No Excuse for Being Discourteous When Offered Help It was a trip, plain and simple, neither my leg giving way nor a fall. It was MS-related because it was directly caused by foot drop; the toe of my left shoe caught on the tiniest ridge at the bottom of…
February 20, 2017 Columns by admin MS Patient’s Pick of the Week’s News: BFitLifestyles, Cannabis, ARNet, Bioness and More Here`s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Fitness Trainer and MS Patient, Dolly Stokes, Launches BFitLifestyles Website with Husband Looking after what you eat and exercising according to your abilities apparently can help alleviate symptoms of many chronic illnesses including…
February 16, 2017 Columns by admin MS Love and Care, as Only a Superwife Can Provide Thoughts of love were brought to the forefront of many people’s minds on Valentine’s Day, which is widely celebrated by couples both young and not so young. They usually buy cards and enjoy romantic dinners. In our…
February 13, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Obamacare, Traditional Medicine, Insoles, Biomarkers, Massage Here’s my Pick of the Week’s News as published in Multiple Sclerosis News Today. People with Chronic Diseases Support Obamacare More Than General Public, Survey Finds As everyone must know, throughout the world, politics in the U.S. has become extremely volatile and one of the focuses is…
February 9, 2017 Columns by admin Worry Less to Reduce Unnecessary Stress Stress is like a light that turns on when you need it. But when you can’t turn it off, you run the risk of burnout, which can impact your health, according to the U.S. National MS Society. I often have said that…
February 6, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Stem Cells, Cognitive, Gilenya, Tecfidera, Zinbryta Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Clinical Trial Supports Stem Cell Transplants to Treat RMS Patients with High Disease Activity It’s no secret to readers of this column and, indeed, to the wider MS community, that I am convinced…
January 30, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Sense of Smell, Women, Biomarkers and More Here is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Sense of Smell Impaired in Half of Multiple Sclerosis Patients in Study For very many years I have known that my sense of smell has not been as good as that considered normal…
January 23, 2017 Columns by admin Pick of the Week’s News: Clinical Trial, Collaboration, Oral DMTs, Resilience, Cannabis Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. MS Patients with Spasticity Needed for Study of Extended-release Baclofen Capsules Now here’s a rare chance to get involved in a clinical trial – as long as you have MS and experience some form…
January 19, 2017 Columns by admin MS Society Award Nominations: We All Are Stars Nominations are being sought for individuals and groups for the U.K.’s MS Society Awards 2017. Organizers say the awards will recognize the stars of the MS community and their contributions during 2016. While not wishing to denigrate…
January 16, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Partners, Traffic, Patent, B-cells, Award Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Sanofi, ImmuNext Partner to Develop Antibody to Treat Range of Autoimmune Diseases Big news on the business front is the alliance of two companies, Sanofi and ImmuNext, that have announced an agreement…
January 13, 2017 Columns by admin Like These Athletes, We All Should be Putting Our Best Feet Forward It’s often said of the 2.5 million of people in the world who have multiple sclerosis that no two have the same symptoms. Indeed, that is why it is known as the Snowflake disease. And the wide variety of symptoms can be well-illustrated by looking…
January 9, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Diet and Exercise, Tolerability, CHANGE-MS and More Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Inactivity and Poor Diet Are Common Risk Factors Among MS Patients, Study Says For years, people with MS have been advised to exercise more and eat healthy foods. That is advice given to…
January 5, 2017 Columns by admin Phoebe’s HSCT Story: Back home (Last in a Series) Phoebe Scopes was the first international patient to receive Hematopoietic Stem Cell Transplantation (HSCT) therapy for multiple sclerosis in Moscow. In this fourth, and last, part of her story, we join Phoebe on her return home to the London. Ian: What is your post-HSCT MS state from getting home…
December 19, 2016 Columns by admin MS Patient’s Picks of the Week’s News: Zinbryta, Gadolinum, Calcium, Brain’s Defense, Antibiotic Here are my Picks of the Week’s News, as published by Multiple Sclerosis News Today. Zinbryta Approved in Canada as Once-Monthly Treatment for Relapsing MS It can only be good for people with relapsing MS in Canada that they now may receive Zinbryta as a treatment.
December 15, 2016 Columns by admin Phoebe Scopes, British HSCT Pioneer in Moscow, Part 2 Last week, I introduced you to Phoebe Scopes, the very first MS patient from another country to undergo hematopoietic stem cell transplantation (HSCT) in Moscow. Today, in Part 2, we pick up the story of the 46-year-old who lives in London. Ian: So, you had done lots of research. How…
December 12, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Imbalances, Attack, Hormonal, Vitamin D, Copaxone Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Imbalances in Brain Microbiota May Be Behind Demyelination in MS, Study Says Good to see that new research involving humans (NOT mice this time) may lead to better understanding of MS. Alterations…
